Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
Read More General news updates Fukushima disaster strikes again: The terrifying truth about a worker’s exposure In a startling development at the Fukushima nuclear plant, authorities announced on Thursday that a high level of… byPallavi MadhirajuDecember 16, 2023